SEC Form 4 · accession 0001140361-16-086061
RESMED INC · RMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael J. Farrell
Officer — Chief Executive Officer
Period of report
Nov 11, 2016
Accepted (ET)
Nov 14, 2016 · 10:50 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000943819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ResMed Common StockF1,F2 | Nov 11, 2016 | F | 6,469 | $59.85 | D | 191,653 | D | |
| ResMed Common StockF3 | Nov 11, 2016 | F | 8,685 | $59.85 | D | 182,968 | D | |
| ResMed Common StockF4 | Nov 11, 2016 | F | 8,518 | $59.85 | D | 174,450 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Disposition to issuer for tax withholding upon vesting of performance-based Restricted Stock Units granted on 11/13/2013.
- F2Includes 316 shares of ResMed stock purchased on 10/31/2016, through the ResMed Employee Stock Purchase Plan.
- F3Disposition to issuer for tax withholding upon vesting of performance-based Restricted Stock Units granted on 11/19/2014.
- F4Disposition to issuer for tax withholding upon vesting of performance-based Restricted Stock Units granted on 11/19/2015.